Your Article Summary
First New Oral Class of HIV Medicine in Over a Decade Launched
PharmiWeb, 11/20/08
Pfizer’s Celsentri (maraviroc), an important new HIV medicine and the first new oral class of HIV treatment in more than a decade, has been made available for treatment experienced patients in the UK. Discovered and developed by Pfizer scientists in Sandwich, Kent, maraviroc represents a significant innovation in the treatment of HIV infection.
| Previous Article | Next Article |
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Medical Calculators: Online Tool for Pediatricians
Indian Pediatrics, 06/30/09
Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
Teva Pharmaceutical Industries, 07/02/09
Prevalence and Characteristics of Vibrator Use by Women in the United States: Results from a Nationally Representative Study
The Journal of Sexual Medicine, 05/13/09
Article Search
Sponsor


See Latest Articles


